Treatment with targeted temperature management after out-of-hospital cardiac arrest with shockable rhythm increases the risk for ventilator-associated pneumonia. The researchers aimed to better understand...
Authors of a new study investigated the safety and immunogenicity of 3 formulations of an investigational vaccine, which contains RSV fusion protein engineered to preferentially maintain a prefusion...
Because the timing of antiretroviral therapy may affect the trajectory of HIV-related inflammation, authors of a new study investigated the effect of early therapy initiation on the cerebrospinal fluid and...
Understanding the barriers to influenza vaccination is key to improving annual vaccination rates and reducing the burden of influenza. In a new study, researchers analyzed survey data to better understand...
In 2013, antibiotic-resistant organisms were responsible for nearly twice as many fatalities in the United States as previously reported, according to a new report from the US Centers for Disease Control...
After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
For the FLU-IVIG trial, researchers evaluated the safety and efficacy of anti-influenza hyperimmune intravenous immunoglobulin to better understand the clinical benefits for patients with influenza.
For the FLU-IVIG trial, researchers evaluated the safety and efficacy of anti-influenza hyperimmune intravenous immunoglobulin to better understand the clinical benefits for patients with influenza.
